286 related articles for article (PubMed ID: 19506954)
21. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
[TBL] [Abstract][Full Text] [Related]
22. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
[TBL] [Abstract][Full Text] [Related]
24. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
[TBL] [Abstract][Full Text] [Related]
25. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
[TBL] [Abstract][Full Text] [Related]
26. Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures.
Tokmak H; Kaban K; Muslumanoglu M; Demirel M; Aktan S
World J Surg Oncol; 2014 Jul; 12():205. PubMed ID: 25016393
[TBL] [Abstract][Full Text] [Related]
27. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.
Ponzone R; Cont NT; Maggiorotto F; Cassina E; Mininanni P; Biglia N; Sismondi P
J Clin Oncol; 2009 Nov; 27(33):5547-51. PubMed ID: 19826123
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node pressure in breast cancer.
Nathanson SD; Mahan M
Ann Surg Oncol; 2011 Dec; 18(13):3791-6. PubMed ID: 21626079
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
30. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P
Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy is precise after primary systemic therapy in stage II-III breast cancer patients.
Reitsamer R; Menzel C; Glueck S; Rettenbacher L; Weismann C; Hutarew G
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():286-90. PubMed ID: 20853048
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy in breast cancer New indications and our experience.
Zanghì G; Rinzirillo NM; Caponnetto AM; Vecchio R; Catania V; Leanza V
Ann Ital Chir; 2015; 86():508-12. PubMed ID: 26898363
[TBL] [Abstract][Full Text] [Related]
33. A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.
Yue T; Zhuang D; Zhou P; Zheng L; Fan Z; Zhu J; Hou L; Yu F; Dong X; Xiao L; He Q
Clin Breast Cancer; 2015 Aug; 15(4):301-6. PubMed ID: 25776198
[TBL] [Abstract][Full Text] [Related]
34. Prospective study evaluating oncological safety of axillary reverse mapping.
Schunemann E; Dória MT; Silvestre JB; Gasperin P; Cavalcanti TC; Budel VM
Ann Surg Oncol; 2014 Jul; 21(7):2197-202. PubMed ID: 24599413
[TBL] [Abstract][Full Text] [Related]
35. [Detection of sentinel lymph node in patients with early stage breast cancer].
Tang J; Yang MT; Fan W; Wang X; Zhang X; Liang XM; Wang X; Xie ZM
Ai Zheng; 2005 Sep; 24(9):1111-4. PubMed ID: 16159435
[TBL] [Abstract][Full Text] [Related]
36. Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of Oncology.
Intra M; Viale G; Vila J; Grana CM; Toesca A; Gentilini O; Galimberti V; Veronesi P; Luini A; Rotmensz N; Bagnardi V; Mattar D; Colleoni M
Ann Surg Oncol; 2015 Jul; 22(7):2372-7. PubMed ID: 25515197
[TBL] [Abstract][Full Text] [Related]
37. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].
Ge J; Yan B; Cao XC
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525
[TBL] [Abstract][Full Text] [Related]
39. Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.
Siso C; de Torres J; Esgueva-Colmenarejo A; Espinosa-Bravo M; Rus N; Cordoba O; Rodriguez R; Peg V; Rubio IT
Ann Surg Oncol; 2018 Mar; 25(3):784-791. PubMed ID: 29197044
[TBL] [Abstract][Full Text] [Related]
40. Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer.
Gatek J; Vrana D; Hnatek L; Bakala J; Dudesek B; Duben J; Musil T
J BUON; 2012; 17(2):265-70. PubMed ID: 22740204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]